E-LIB Suche - Ergebnisse für: Hidekazu Shirota

1

Dabrafenib and trametinib administration in patients with B..:

Shimoi, Tatsunori ; Sunami, Kuniko ; Tahara, Makoto...
eClinicalMedicine. 69 (2024) - p. 102447 , 2024

Link: https://doi.org/10.1016/..

2

Correlation between Efficacy and Cardiovascular Adverse Eve..:

Yoshida, Yuya ; Takahashi, Masanobu ; Komine, Keigo...
Internal Medicine. , 2024

Link: https://doi.org/10.2169/..

3

Genome-wide DNA methylation status is a predictor of the ef..:

Ouchi, Kota ; Takahashi, Shin ; Sasaki, Keiju...
International Journal of Colorectal Disease. 39 (2024) 1 - p. , 2024

Link: https://doi.org/10.1007/..

4

Chylous Ascites Associated with Advanced Pancreatic Cancer ..:

Imai, Hiroo ; Saijo, Ken ; Takenaga, Noriko...
Current Oncology. 31 (2024) 3 - p. 1477-1482 , 2024

Link: https://doi.org/10.3390/..

5

Patient survey on cancer genomic medicine in Japan under th..:

Kage, Hidenori ; Akiyama, Nana ; Chang, Hyangri...
Cancer Science. 115 (2024) 3 - p. 954-962 , 2024

Link: https://doi.org/10.1111/..

6

Human resources for administrative work to carry out a comp..:

Kage, Hidenori ; Oda, Katsutoshi ; Muto, Manabu...
Cancer Science. 114 (2023) 7 - p. 3041-3049 , 2023

Link: https://doi.org/10.1111/..

7

TP53 Gain-of-Function Mutation is a Poor Prognostic Factor ..:

Wakayama, Shonosuke ; Ouchi, Kota ; Takahashi, Shin...
Clinical Colorectal Cancer. 22 (2023) 3 - p. 327-338 , 2023

Link: https://doi.org/10.1016/..

8

Antibiotics May Interfere with Nivolumab Efficacy in Patien..:

Ueta, Reio ; Imai, Hiroo ; Saijo, Ken...
Oncology. 102 (2023) 3 - p. 252-259 , 2023

Link: https://doi.org/10.1159/..

9

Depth of response may predict clinical outcome in patients ..:

Saijo, Ken ; Imai, Hiroo ; Ouchi, Kota...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

10

Comparison of Efficacy and Safety between Carboplatin-Etopo..:

Imai, Hiroo ; Saijo, Ken ; Kawamura, Yoshifumi...
Oncology. 102 (2023) 5 - p. 359-367 , 2023

Link: https://doi.org/10.1159/..

11

Management of patients with presumed germline pathogenic va..:

Kawamura, Maako ; Shirota, Hidekazu ; Niihori, Tetsuya...
Journal of Human Genetics. 68 (2023) 6 - p. 399-408 , 2023

Link: https://doi.org/10.1038/..

12

Distinct role of CD8 cells and CD4 cells in antitumor immun..:

Umegaki, Sho ; Shirota, Hidekazu ; Kasahara, Yuki..
Cancer Science. 114 (2023) 8 - p. 3076-3086 , 2023

Link: https://doi.org/10.1111/..

13

BRAF and MEK Inhibitor Treatment for Metastatic Undifferent..:

Saijo, Ken ; Imai, Hiroo ; Katayama, Hiromichi...
Case Reports in Oncology. 15 (2022) 2 - p. 762-769 , 2022

Link: https://doi.org/10.1159/..

14

Antibiotic Treatment Improves the Efficacy of Oxaliplatin-B..:

Imai, Hiroo ; Saijo, Ken ; Komine, Keigo...
Cancer Management and Research. 14 (2022) - p. 1259-1266 , 2022

Link: https://doi.org/10.2147/..

15

Clinical decisions by the molecular tumor board on comprehe..:

Shirota, Hidekazu ; Komine, Keigo ; Takahashi, Masanobu...
Cancer Medicine. 12 (2022) 5 - p. 6170-6181 , 2022

Link: https://doi.org/10.1002/..